Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.60 +0.07%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
- Apple Touched $5 Trillion and Then Gave It Back. Gabriel Adams, Senior Markets Strategist at Swiftvale, on Reading a Milestone and a Reversal in the Same Week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
